These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
737 related articles for article (PubMed ID: 31861233)
21. LncOCMRL1 promotes oral squamous cell carcinoma growth and metastasis via the RRM2/EMT pathway. Lu N; Jiang Q; Xu T; Gao Q; Wang Y; Huang Z; Huang Z; Xu X J Exp Clin Cancer Res; 2024 Sep; 43(1):267. PubMed ID: 39343925 [TBL] [Abstract][Full Text] [Related]
22. Signal regulatory protein α associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages. Ye X; Zhang J; Lu R; Zhou G Oncotarget; 2016 Dec; 7(49):81305-81321. PubMed ID: 27793032 [TBL] [Abstract][Full Text] [Related]
23. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC. Wang LH; Xu M; Fu LQ; Chen XY; Yang F Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678 [TBL] [Abstract][Full Text] [Related]
24. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma. Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842 [TBL] [Abstract][Full Text] [Related]
25. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma. Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774 [TBL] [Abstract][Full Text] [Related]
26. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline. Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511 [TBL] [Abstract][Full Text] [Related]
27. Silencing ANLN hinders the proliferation, migration, invasion, and angiogenesis of oral squamous cell carcinoma. Wu S; Li D; Li L; Zhao J; Zhang H; Zhou X; Wang S; Mo Y; Li P Pathol Res Pract; 2024 Oct; 262():155563. PubMed ID: 39217772 [TBL] [Abstract][Full Text] [Related]
28. Effects of DSPP and MMP20 Silencing on Adhesion, Metastasis, Angiogenesis, and Epithelial-Mesenchymal Transition Proteins in Oral Squamous Cell Carcinoma Cells. Aseervatham J; Ogbureke KUE Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630820 [TBL] [Abstract][Full Text] [Related]
29. TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma. Chen L; Li YC; Wu L; Yu GT; Zhang WF; Huang CF; Sun ZJ J Cell Mol Med; 2018 Feb; 22(2):1337-1349. PubMed ID: 29193723 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway. Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019 [TBL] [Abstract][Full Text] [Related]
31. Targeting CD47 Inhibits Tumor Development and Increases Phagocytosis in Oral Squamous Cell Carcinoma. Ye XJ; Yang JG; Tan YQ; Chen XJ; Zhou G Anticancer Agents Med Chem; 2021; 21(6):766-774. PubMed ID: 32748759 [TBL] [Abstract][Full Text] [Related]
32. PRELP inhibits the progression of oral squamous cell carcinoma via inactivation of the NF-κB pathway. Sun X; Chai L; Wang B; Zhou J Arch Oral Biol; 2024 Nov; 167():106068. PubMed ID: 39151326 [TBL] [Abstract][Full Text] [Related]
34. Ectopic expression of MELK in oral squamous cell carcinoma and its correlation with epithelial mesenchymal transition. Li B; Xu X; Bin X; Zhou J; Tang Z Aging (Albany NY); 2021 May; 13(9):13048-13060. PubMed ID: 33962400 [TBL] [Abstract][Full Text] [Related]
35. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma. Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma. Wang XL; Wang S; Wu ZZ; Yang QC; Li H; Xiong HG; Wan SC; Sun ZJ Int J Med Sci; 2020; 17(11):1598-1609. PubMed ID: 32669963 [TBL] [Abstract][Full Text] [Related]
37. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas. Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037 [TBL] [Abstract][Full Text] [Related]
38. Carbonic Anhydrase III Promotes Cell Migration and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. Chu YH; Su CW; Hsieh YS; Chen PN; Lin CW; Yang SF Cells; 2020 Mar; 9(3):. PubMed ID: 32183030 [TBL] [Abstract][Full Text] [Related]
39. Thymosin β4 induces proliferation, invasion, and epithelial-to-mesenchymal transition of oral squamous cell carcinoma. Hong KO; Lee JI; Hong SP; Hong SD Amino Acids; 2016 Jan; 48(1):117-27. PubMed ID: 26276576 [TBL] [Abstract][Full Text] [Related]
40. Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data. Liu Z; Zhou W; Lin C; Wang X; Zhang X; Zhang Y; Yang R; Chen W; Cao W Aging (Albany NY); 2020 Dec; 13(2):2379-2396. PubMed ID: 33318296 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]